Tratamiento sintomático y del brote de esclerosis múltiple

Prieto González, José María.
Med. clín (Ed. impr.) ; 143(supl.3): 39-43, dic. 2014.
Artículo en Español | IBECS (España) | ID: ibc-136232

Documentos relacionados

  1. Novel and Emerging Treatments to Target Pathophysiological Mechanisms in Various Phenotypes of Multiple Sclerosis.
  2. Cost-utility of oral methylprednisolone in the treatment of multiple sclerosis relapses: Results from the COPOUSEP trial.
  3. Immunology of relapse and remission in multiple sclerosis.
  4. Clinical trials in multiple sclerosis: past, present, and future.
  5. Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting.
  6. Assessing heterogeneity of treatment effect in multiple sclerosis trials.
  7. Best practices in phase III clinical trials on DMTs for multiple sclerosis: a systematic analysis and appraisal of published trials.
  8. Management of Possible Multiple Sclerosis.
  9. [Treatments for multiple sclerosis: update].
  10. Nucleic Acids as Novel Therapeutic Modalities to Address Multiple Sclerosis Onset and Progression.